Park Chulwoo, Vagoyan Zabala Pyramida, Irene Trisnadi Airi
Department of Public Health and Recreation, San José State University, San Jose, CA, United States.
Department of Psychology, San José State University, San Jose, CA, United States.
Prev Med Rep. 2023 Sep 22;36:102436. doi: 10.1016/j.pmedr.2023.102436. eCollection 2023 Dec.
With the increased accessibility of COVID-19 vaccine, many households have had concerns when vaccinating children, leading to vaccine hesitancy. This study examined the COVID-19 vaccine and booster hesitancy among children aged 6 months-5 years, 5-11 years, and 12-17 years in the United States. We analyzed data from Phase 3.8 (March 1, 2023 to May 8, 2023) of the Household Pulse Survey (HPS) collected by the U.S. Census Bureau. We conducted survey-weighted multiple logistic regression models in vaccine hesitancy among respondents with children from those three different age groups, controlling for various demographic factors such as COVID-19 vaccination status, COVID-19 positive test results, race/ethnicity, gender at birth, age, region, marital status, educational attainment, household income, health insurance, and children's school type. The percentage of respondents indicating hesitancy towards vaccinating their children (expressing uncertainty, probably not, or definitely not) decreased as their children's age increased. Specifically, the proportion was 57.4% for children aged 6 months-5 years, 43.3% for children aged 5-11 years, and 25.9% for children aged 12-17 years. Concerns about possible side effects of the COVID-19 vaccine were the most prevalent among respondents who expressed vaccine hesitancy, regardless of the level of hesitancy, while those with strong hesitancy showed higher proportions of not believing their children need a vaccine, lack of trust in COVID-19 vaccines and the government, and parents/guardians not vaccinating their children. This study provide insight into our current situation, aiming to build assurance among households regarding the efficacy and benefits of COVID-19 vaccines for children of all ages.
随着新冠疫苗的可及性增加,许多家庭在给孩子接种疫苗时产生了担忧,导致疫苗犹豫现象。本研究调查了美国6个月至5岁、5至11岁以及12至17岁儿童中对新冠疫苗及加强针的犹豫情况。我们分析了美国人口普查局收集的家庭脉搏调查(HPS)第3.8阶段(2023年3月1日至2023年5月8日)的数据。我们对来自这三个不同年龄组有孩子的受访者中疫苗犹豫情况进行了调查加权多元逻辑回归模型分析,控制了各种人口统计学因素,如新冠疫苗接种状况、新冠病毒检测阳性结果、种族/族裔、出生时性别、年龄、地区、婚姻状况、教育程度、家庭收入、医疗保险以及孩子的学校类型。表示对给孩子接种疫苗犹豫(表示不确定、可能不接种或肯定不接种)的受访者比例随着孩子年龄的增长而下降。具体而言,6个月至5岁儿童的比例为57.4%,5至11岁儿童为43.3%,12至17岁儿童为25.9%。对新冠疫苗可能的副作用的担忧在表示疫苗犹豫 的受访者中最为普遍,无论犹豫程度如何,而强烈犹豫的受访者中,不认为孩子需要接种疫苗、对新冠疫苗和政府缺乏信任以及父母/监护人不给孩子接种疫苗的比例更高。本研究深入了解了我们当前的情况,旨在增强家庭对新冠疫苗对各年龄段儿童的有效性和益处的信心。